Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Ended earlyNCT05904496What this trial is testingBGB-30813 Alone or in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid Tumors BeiGene 44
Large-scale testing (Phase 3)Study completedNCT03191786What this trial is testingAtezolizumab Compared With a Single-Agent Chemotherapy in Treatment Naïve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet ChemotherapyWho this might be right forNon-Small Cell Lung Cancer Hoffmann-La Roche 453
Early research (Phase 1)WithdrawnNCT06681870What this trial is testingASP1893 in Adults With Advanced CLDN6-positive Solid TumorsWho this might be right forCLDN6-positive Solid TumorOvarian CancerEndometrial Cancer+3 more Astellas Pharma Global Development, Inc.
Early research (Phase 1)Looking for participantsNCT06066138What this trial is testingTherapeutic Drug Monitoring-Based Atezolizumab DosingWho this might be right forLocally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more National Cancer Institute (NCI) 30
Early research (Phase 1)Ended earlyNCT03054038What this trial is testingAfatinib and Necitumumab in Patients With EGFR Mutation Positive Advanced or Metastatic Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Carcinoma Vanderbilt-Ingram Cancer Center 22
Large-scale testing (Phase 3)Study completedNCT03150875What this trial is testingA Study Comparing the Efficacy and Safety Between IBI308 and Docetaxel in Patients With Advanced or Metastatic NSCLCWho this might be right forNon-small Cell Lung Cancer Innovent Biologics (Suzhou) Co. Ltd. 290
Large-scale testing (Phase 3)Study completedNCT00004199What this trial is testingPrinomastat and Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Non-small Cell Lung CancerWho this might be right forLung Cancer Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT06105021What this trial is testingPhase I Study of Autologous CD8+ and CD4+ Engineered T Cell Receptor T Cells in Subjects With Advanced or Metastatic Solid TumorWho this might be right forPancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerColorectal Cancer+2 more Affini-T Therapeutics, Inc. 100
Early research (Phase 1)WithdrawnNCT03231475What this trial is testingPhase I Study of SPH1188-11 in NSCLCWho this might be right forNSCLC Stage IIIBNSCLC Stage IV Shanghai Pharmaceuticals Holding Co., Ltd
Early research (Phase 1)Study completedNCT03810807What this trial is testingStudy of Dacomitinib and Osimertinib for Patients With Advanced EGFR Mutant Lung CancerWho this might be right forMetastatic Non-small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02049060What this trial is testingStudy of the Combination of Tivantinib Plus Pemetrexed and CarboplatinWho this might be right forMalignant Pleural MesotheliomaNonsquamous Nonsmall Cell Neoplasm of Lung Armando Santoro, MD 31
Early research (Phase 1)Study completedNCT01155258What this trial is testingTemsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsWho this might be right forExtensive Stage Small Cell Lung CancerHereditary ParagangliomaMale Breast Cancer+45 more University of Southern California 19
Large-scale testing (Phase 3)UnknownNCT04500717What this trial is testingAlmonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Tumor Suppressor Gene MutationWho this might be right forNon Small Cell Lung Cancer Cancer Institute and Hospital, Chinese Academy of Medical Sciences 460
Testing effectiveness (Phase 2)Active Not RecruitingNCT05466149What this trial is testingEfficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 InsertionWho this might be right forNSCLC Allist Pharmaceuticals, Inc. 100
Early research (Phase 1)Looking for participantsNCT04913285What this trial is testingEvaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid TumorsWho this might be right forSolid Tumor, AdultNon-small Cell Lung CancerMelanoma Pierre Fabre Medicament 400
Testing effectiveness (Phase 2)UnknownNCT05741021What this trial is testingA Phase II Study of Rulonilimab Combined With Chemotherapy in the First-Line Treatment for Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-small Cell Lung CancerNSCLCPD-1 Shandong New Time Pharmaceutical Co., LTD 84
Early research (Phase 1)WithdrawnNCT01702714What this trial is testingRO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic DiseaseWho this might be right forNon-Squamous Non-Small Cell Lung Cancer Hoffmann-La Roche
Not applicableEnded earlyNCT00904514What this trial is testingStudy of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical TrialWho this might be right forCancer National Institutes of Health Clinical Center (CC) 241
Not applicableStudy completedNCT05034926What this trial is testingNivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and CyprusWho this might be right forNon-Small Cell Lung Cancer Bristol-Myers Squibb 212